The english version of the website of the School of Medicine is under development


Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

TitleManagement goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
Publication TypeJournal Article
Year of Publication2018
AuthorsBiegstraaten, M., Cox T. M., Belmatoug N., Berger M. G., Collin-Histed T., S Dahl V., Di Rocco M., Fraga C., Giona F., Giraldo P., Hasanhodzic M., Hughes D. A., Iversen P. O., Kiewiet A. I., Lukina E., Machaczka M., Marinakis T., Mengel E., Pastores G. M., Plöckinger U., Rosenbaum H., Serratrice C., Symeonidis A., Szer J., Timmerman J., Tylki-Szymańska A., M Hubshman W., Zafeiriou D. I., Zimran A., & Hollak C. E. M.
JournalBlood Cells Mol Dis
Date Published2018 Feb
KeywordsConsensus, Disease Management, Europe, Gaucher Disease, Humans, Quality of Life

Gaucher Disease type 1 (GD1) is a lysosomal disorder that affects many systems. Therapy improves the principal manifestations of the condition and, as a consequence, many patients show a modified phenotype which reflects manifestations of their disease that are refractory to treatment. More generally, it is increasingly recognised that information as to how a patient feels and functions [obtained by patient- reported outcome measurements (PROMs)] is critical to any comprehensive evaluation of treatment. A new set of management goals for GD1 in which both trends are reflected is needed. To this end, a modified Delphi procedure among 25 experts was performed. Based on a literature review and with input from patients, 65 potential goals were formulated as statements. Consensus was considered to be reached when ≥75% of the participants agreed to include that specific statement in the management goals. There was agreement on 42 statements. In addition to the traditional goals concerning haematological, visceral and bone manifestations, improvement in quality of life, fatigue and social participation, as well as early detection of long-term complications or associated diseases were included. When applying this set of goals in medical practice, the clinical status of the individual patient should be taken into account.

Alternate JournalBlood Cells Mol. Dis.
PubMed ID28274788
Grant ListMR/K015338/1 / / Medical Research Council / United Kingdom
MR/K025570/1 / / Medical Research Council / United Kingdom


Secretariat of the School of Medicine


Schoole of Medicince presence in social networks
Follow Us or Connect with us.